ISM, UMR CNRS 5255, Université Bordeaux , 33405 Talence Cedex, France.
Acc Chem Res. 2014 Feb 18;47(2):494-503. doi: 10.1021/ar400168s. Epub 2013 Nov 11.
Catalysis by palladium derivatives is now one of the most important tools in organic synthesis. Whether researchers design palladium nanoparticles (NPs) or nanoparticles occur as palladium complexes decompose, these structures can serve as central precatalysts in common carbon-carbon bond formation. Palladium NPs are also valuable alternatives to molecular catalysts because they do not require costly and toxic ligands. In this Account, we review the role of "homeopathic" palladium catalysts in carbon-carbon coupling reactions. Seminal studies from the groups of Beletskaya, Reetz, and de Vries showed that palladium NPs can catalyze Heck and Suzuki-Miyaura reactions with aryl iodides and, in some cases, aryl bromides at part per million levels. As a result, researchers coined the term "homeopathic" palladium catalysis. Industry has developed large-scale applications of these transformations. In addition, chemists have used Crooks' concept of dendrimer encapsulation to set up efficient nanofilters for Suzuki-Miyaura and selective Heck catalysis, although these transformations required high PdNP loading. With arene-centered, ferrocenyl-terminated dendrimers containing triazolyl ligands in the tethers, we designed several generations of dendrimers to compare their catalytic efficiencies, varied the numbers of Pd atoms in the PdNPs, and examined encapsulation vs stabilization. The catalytic efficiencies achieved "homeopathic" (TON = 540 000) behavior no matter the PdNP size and stabilization type. The TON increased with decreasing the Pd/substrate ratio, which suggested a leaching mechanism. Recently, we showed that water-soluble arene-centered dendrimers with tri(ethylene glycol) (TEG) tethers stabilized PdNPs involving supramolecular dendritic assemblies because of the interpenetration of the TEG branches. Such PdNPs are stable and retain their "homeopathic" catalytic activities for Suzuki-Miyaura reactions for months. (TONs can reach 2.7 × 10(6) at 80 °C for aryl bromides and similar values for aryl iodides at 28 °C.) Sonogashira reactions catalyzed by these PdNPs are quantitative with only 0.01% Pd/mol substrate. Kato's group has reported remarkable catalytic efficiencies for mesoporous catalysts formed by polyamidoamine (PAMAM) dendrimer polymerizations. These and other mesoporous structures could allow for catalyst recycling, with efficiencies approaching the "homeopathic" behavior. In recent examples of Suzuki-Miyaura reactions of aryl chlorides, chemists achieved truly "homeopathic" catalysis when a surfactant such as a tetra-n-butylammonium halide or an imidazolium salt was used in stoichiometric quantities with substrate. These results suggest that the reactive halide anion of the salt attacks the neutral Pd species to form a palladate. In the case of aryl chlorides, the reaction may occur through the difficult, rate-limiting oxidative-addition step.
钯衍生物的催化作用现在是有机合成中最重要的工具之一。无论是研究人员设计钯纳米粒子 (NPs) 还是钯配合物分解时出现纳米粒子,这些结构都可以作为常见碳-碳键形成的中心前催化剂。钯 NPs 也是分子催化剂的有价值替代品,因为它们不需要昂贵且有毒的配体。在本账户中,我们回顾了“顺势疗法”钯催化剂在碳-碳偶联反应中的作用。Beletskaya、Reetz 和 de Vries 小组的开创性研究表明,钯 NPs 可以在百万分之几的水平下催化 Heck 和 Suzuki-Miyaura 反应,用芳基碘化物,在某些情况下用芳基溴化物。因此,研究人员创造了“顺势疗法”钯催化这个术语。工业界已经开发出了这些转化的大规模应用。此外,化学家们还使用 Crooks 的树状大分子封装概念来建立有效的 Suzuki-Miyaura 和选择性 Heck 催化纳米过滤器,尽管这些转化需要高 PdNP 负载。我们使用含有三唑基配体的芳基中心、二茂铁末端的树状大分子设计了几代树状大分子来比较它们的催化效率,改变了 PdNPs 中的 Pd 原子数量,并检查了封装与稳定。无论 PdNP 的大小和稳定类型如何,实现了“顺势疗法”(TON = 540000)行为。TON 随着 Pd/底物比的降低而增加,这表明存在浸出机制。最近,我们表明,由于三(乙二醇)(TEG)支链的穿插,含有三(乙二醇)(TEG)支链的水溶性芳基中心树状大分子稳定 PdNPs 涉及超分子树状大分子组装,可实现 Suzuki-Miyaura 反应的“顺势疗法”催化活性数月。(TON 可以在 80°C 下达到 2.7×10(6),对于芳基溴化物,在 28°C 下对于芳基碘化物也有类似的值。)这些 PdNPs 催化的 Sonogashira 反应具有定量性,底物中只需 0.01% Pd/mol 即可。Kato 小组报道了由聚酰胺胺(PAMAM)树状大分子聚合形成的介孔催化剂的显著催化效率。这些和其他介孔结构可以允许催化剂回收,效率接近“顺势疗法”行为。在芳基氯化物的 Suzuki-Miyaura 反应的最新实例中,当使用等摩尔量的表面活性剂(如四丁基卤化铵或咪唑鎓盐)与底物一起使用时,化学家们实现了真正的“顺势疗法”催化。这些结果表明,盐的反应性卤化物阴离子攻击中性 Pd 物种以形成钯酸盐。对于芳基氯化物,反应可能通过困难的、速率限制的氧化加成步骤发生。